Lily Yu is a skilled statistical programming professional specializing in biostatistics and drug development. They served as a Biostatistical Programming Manager at Amgen from 2006 to 2013, then progressed through various roles, including Sr Manager at Onyx Pharmaceuticals and Manager at Gilead Sciences. Currently, Lily is the Director of Biostatistical Programming at Pfizer, where they have been since 2018. They are pursuing dual Master's degrees in Biochemistry & Molecular Biology from Nankai University and Statistics from California State University-East Bay.
This person is not in the org chart
This person is not in any teams
This person is not in any offices